Sarcopenia Treatment Market size to Reach USD 4.97 Billion by 2031 as Aging Population and Nutritional Interventions Drive Growth

Sarcopenia Treatment Market Analysis 

 According to Mordor Intelligence, the sarcopenia treatment market size was valued at USD 3.74 billion in 2026 and is projected to reach USD 4.97 billion by 2031, growing at a CAGR of 5.85% during the forecast period. This sarcopenia treatment market forecast reflects rising awareness, improved diagnosis rates, and expanding treatment pathways across developed and emerging regions. 

Sarcopenia, characterized by progressive loss of skeletal muscle mass and strength, is increasingly recognized as a serious public health concern. As global populations age, the demand for nutritional supplementation, pharmacological therapies, and structured rehabilitation programs is expanding. The sarcopenia treatment industry is supported by government-backed healthy aging programs and broader clinical focus on fall prevention, frailty management, and post-hospital recovery. 

Key Trends Shaping the Sarcopenia Treatment Market 

Aging Population and Rising Fall-Related Costs 

The rapid increase in the elderly population remains one of the strongest drivers of sarcopenia treatment market growth. Countries across Asia-Pacific, North America, and Europe are experiencing demographic shifts that increase the prevalence of muscle degeneration disorders. Healthcare systems are linking sarcopenia management to fall prevention strategies, reducing hospital admissions and long-term care costs.  

Growing Adoption of Protein and Nutritional Supplements 

Protein supplementation continues to hold a significant sarcopenia treatment market share. Whey protein enriched with leucine, along with vitamin D and calcium combinations, has become common in geriatric care. Hospitals frequently recommend these supplements after fracture or surgery to support muscle rebuilding.  

Advancements in Pharmacological Research 

The sarcopenia treatment industry is also witnessing increased research activity targeting myostatin and ActRII pathways. Regulatory filings for novel biologics indicate a shift toward disease-specific therapies. If approvals materialize within the sarcopenia treatment market forecast period, prescription drugs may alter sarcopenia treatment market share dynamics by expanding reimbursable treatment options. 

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/sarcopenia-treatment-market?utm_source=industrytoday  

Sarcopenia Treatment Market Segmentation Analysis 

By Treatment Type 

• Protein supplements 
• Myostatin inhibitors 
• Selective androgen receptor modulators 
• Vitamins and combination therapies 

By Route of Administration 

• Oral 
• Parenteral 

By Distribution Channel 

• Hospital pharmacies 
• Retail pharmacies 
• Online pharmacies 

By End User 

• Hospitals 
• Specialized clinics 
• Home-care settings 

By Patient Type 

• Primary sarcopenia 
• Secondary sarcopenia 
• Post-acute sarcopenia 

By Geography 

• North America 
• Europe 
• Asia-Pacific 
• Rest of the World 

Explore Our Full Library of Healthcare Research  Report:    https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=industrytoday 

Competitive Landscape in the Sarcopenia Treatment Industry 

The sarcopenia treatment industry is moderately fragmented, combining global nutrition companies with biotechnology firms focused on drug development. Established players dominate nutritional supplementation, while emerging biotech firms are advancing clinical-stage therapeutics. 

Key Players 

• Nestle Health Science 
• Biophytis SA 
• Bayer AG 
• Pfizer Inc. 
• Abbott Laboratories 

Explore more insights on sarcopenia treatment competitive landscape: https://www.mordorintelligence.com/industry-reports/sarcopenia-treatment-market/companies?utm_source=industrytoday  

Conclusion:  

The sarcopenia treatment market forecast reflects consistent demand driven by demographic aging, clinical awareness, and structured nutrition programs. While protein supplementation currently anchors the sarcopenia treatment industry, pharmacological therapies may redefine sarcopenia treatment market trends over the coming years. 

Overall, the sarcopenia treatment market size is positioned for steady progress, supported by balanced contributions from nutritional, clinical, and pharmaceutical segments. As healthcare systems place stronger emphasis on muscle health and functional independence, the sarcopenia treatment industry is expected to maintain its upward trajectory throughout the forecast period. 

Get detailed insights on the sarcopenia treatment market:  https://www.mordorintelligence.com/industry-reports/sarcopenia-treatment-market?utm_source=industrytoday  

Industry Related Reports 

Sarcopenia Treatment Market:  https://www.mordorintelligence.com/industry-reports/sarcopenia-treatment-market?utm_source=industrytoday 

Multiple Sclerosis Therapeutics Market size: https://www.mordorintelligence.com/industry-reports/multiple-sclerosis-therapeutics-market?utm_source=industrytoday 

Neurodegenerative Disease Market share:  https://www.mordorintelligence.com/industry-reports/neurodegenerative-disease-market?utm_source=industrytoday 

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com 

https://www.mordorintelligence.com/